Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis

• Main Authors: Rao, S.P.S., Lakshminarayana, S.B., Kondreddi, R.R., Herve, M., Camacho, L.R., Bifani, P., Kalapala, S.K., Jiricek, J., Ma, N.L., Tan, B.H., Ng, S.H., Nanjundappa, M., Ravindran, S., Seah, P.G., Thayalan, P., Lim, S.H., Lee, B.H., Goh, A., Barnes, W.S., Chen, Z., Gagaring, K., Chatterjee, A.K., Pethe, K., Kuhen, K., Walker, J., Feng, G., Babu, S., Zhang, L., Blasco, F., Beer, D., Weaver, M., Dartois, V., Glynne, R., Dick, T., Smith, P.W., Diagana, T.T., Manjunatha, U.H.
• 其他作者: MICROBIOLOGY
• 格式: Article
• 出版: 2016
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/125502
• 機構: National University of Singapore

10.1126/scitranslmed.3007355